Lucira Health Files for Chapter 11 Bankruptcy, Signals Intent to Sell Business
The COVID-19 test kit maker cited waning demand for its COVID-19 tests and unexpected delays in authorization for its combination COVID-19 and influenza test.
The Boston-based company has developed a loop-mediated amplification assay and a novel lateral flow strip technology.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada
The palm-sized single-use instrument uses shallow nasal swabs and nucleic acid amplification to identify COVID-19 and influenzas A and B.
Lucira Health Molecular COVID/Flu Test Gets FDA Emergency Use Authorization
According to the agency, this is the first molecular COVID-19 test to receive FDA authorization following collaboration with the NIH's Independent Test Assessment Program (ITAP).